Trial Outcomes & Findings for Geriatric Core Dataset (G-CODE) for Clinical Research in Elderly Cancer Patients (NCT NCT03976531)

NCT ID: NCT03976531

Last Updated: 2021-01-20

Results Overview

• Recruitment status: COMPLETED
• Target enrollment: 42 participants
• Primary outcome timeframe: Day 1
• Results posted on: 2021-01-20

Participant Flow

Participant milestones

Measure	National Panel of Experts National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Overall Study STARTED	42
Overall Study COMPLETED	42
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Geriatric Core Dataset (G-CODE) for Clinical Research in Elderly Cancer Patients

Baseline characteristics by cohort

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Age, Customized >= 18 years	42 Participants n=5 Participants
Sex: Female, Male Female	16 Participants n=5 Participants
Sex: Female, Male Male	26 Participants n=5 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Question "Do You Live Alone ?" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Question "do You Have a Person or Caregiver Able to Provide Care and Support" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Tool "ADL (Activities of Daily Living)" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Tool "4-IADL (Instrumental Activities of Daily Living)" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Test "Timed Up and Go" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Items "Weight Loss During the Past 6 Months and Body Mass Index (BMI)" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Item "One Cognitive Scale (Mini-Cog)" Should be Retained in the G-CODE	42 Participants

PRIMARY outcome

Timeframe: Day 1

Outcome measures

Measure	National Panel of Experts n=42 Participants National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.
Number of Experts Who Considered That the Item "Char Lson Comorbidity Index" Should be Retained in the G-CODE	42 Participants

Adverse Events

National Panel of Experts

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Pr S Mathoulin-Pélissier

Institut Bergonié

Phone: 33 5 56 33 33 33

Email: s.mathoulin@bordeaux.unicancer.fr

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place